Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 170

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 170
---
 the Arrangement, subject to final determination prior to the Effective Time in accordance with the terms of the Agreement.

| Related Party |     | Common 
 Shares |        |     | Options     
 Exercisable 
 within      
 60 Days of  
 the Record  
 Date        |         |     | Collateral 
 Benefit    |         |     | Change of       
 Control Payment |         |     | Value of Share 
 Consideration  |        |
|:--------------|:----|:-------|-------:|:----|:------------|--------:|:----|:-----------|--------:|:----|:----------------|--------:|:----|:---------------|-------:|
| Steve Forte   |     |        | 25,576 |     |             | 657,972 |     | $          | 617,598 |     | $               | 750,000 |     | $              | 46,002 |
| Michael Zinda |     |        | 48,781 |     |             | 564,253 |     | $          | 161,359 |     | $               |       — |     | $              | 88,781 |

As a result of the foregoing, (i) the Common Shares that Steve Forte beneficially owns, directly or indirectly, or over which he has control or direction (being 25,276 Common Shares or approximately 0.06% of the issued and outstanding Common Shares as of the Record Date (or 683,248 Common Shares or approximately 1.6% of the issued and outstanding Common Shares taking into consideration Common Shares issuable upon the 105

exercise of Options that are exercisable within a period of sixty (60) days following the Record Date)) will be excluded for the purpose of determining if minority approval of the Arrangement is
obtained and (ii) the Common Shares that Michael Zinda beneficially owns, directly or indirectly, or over which he has control or direction (being 48,781 Common Shares or approximately 0.11% of the issued and outstanding Common Shares as of the
Record Date (or 613,304 Common Shares or approximately 1.4% of the issued and outstanding Common Shares taking into consideration Common Shares issuable upon the exercise of Options that are exercisable within a period of sixty (60) days following
the Record Date)) will be excluded for the purpose of determining if minority approval of the Arrangement is obtained.

106

PROPOSAL NO.